BioXcel Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:BTAI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.04 M-12.57 M-18.79 M-14.21 M-11.81 M -57.38 M Cash from investing activities —0000 0 Cash from financing activities 13.2 M137 K37.53 M5.65 M232 K 43.55 M Free cash flow -12.04 M-12.57 M-18.79 M-14.21 M-11.81 M -57.38 M

News

What Makes BioXcel Therapeutics (BTAI) a New Buy Stock

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates

CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?

BioXcel Therapeutics stock initiated with buy rating at Rodman

BioXcel Therapeutics closes $8M registered direct offering

BioXcel Therapeutics raises $8M in registered direct offering

Why Are BioXcel Therapeutics Shares Down Friday? - BioXcel Therapeutics (NASDAQ:BTAI)

BioXcel reports positive Phase 2 data for opioid withdrawal drug

BioXcel Therapeutics Stock Rallies Opioid Study Success - BioXcel Therapeutics (NASDAQ:BTAI)

BioXcel Therapeutics announces milestone and retention bonuses for key executives